New Drug Development and Regulation
U-NEURON Biomedical Presented UA002 Ahead of BioJapan, Impressing International Stakeholders
Regenerative medicine company U-NEURON Biomedical presented its proprietary amniotic fluid stem cell drug candidate UA002 during the Link-J roadshow session prior to BioJapan on October 7. BioJapan is Asia's flagship medical exhibition, serving as an ideal platform for regenerative medicine. The Link-J Global Life Science Session brought together participants from over 10 countries across the Americas, Japan, Europe, Asia, and Australia. Led by the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) of the Ministry of Economic Affairs, the delegation introduced top-performing Taiwanese biomedical companies during the international roadshow.